Pharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydroc...

Lupin Ltd, a prominent name in the pharmaceutical world, revealed on Tuesday that it has gained tentative approval from the US health autho...

The Mumbai-based drug firm's product is the generic equivalent of Mylan Specialty's Depen tablets, which are indicated for the treatment of...

The US drug regulator, after inspecting the two sites, had expressed concerns over quality-control procedures that include handling of out-...

Shares of Lupin were trading 1.36 per cent lower at Rs 749.15 apiece on BSE.

Drug major Lupin is recalling over 23,000 bottles of an antibiotic drug in the US for being sub-potent, US Food and Drug Administration (US...

Quoting IQVIA MAT September data, Lupin said, the said Asthma drug had annual sales of around USD 474.5 million in the US.

Tobramycin inhalation solution USP, 300 mg/5 ml, had sales of $133.6 million in the US as of December 2016, Lupin stated in a release about...

Drug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.

Drug major Lupin has launched its Tri-Lo-Marzia tablets, an oral contraceptive drug, in the US market after getting approval from the Ameri...

Drug major Lupin has appointed Thierry Volle as President of Europe, the Middle-East & Africa (EMEA) with immediate effect based at the com...

Drug major Lupin Ltd today said the company has received certification for International Sustainability Rating Standard, 8th edition (ISRS)...

Drug major Lupin said it has received US health regulator's approval to market a generic version of Sanofi Aventis' Rifadin capsules.

According to IMS Health data, the tablets posted sales of around $ 443.4 million in the US for the twelve months ending March, 2013.

Lupin has received US health regulator's approval to sell its generic version of Glumetza HCl ER Tablets in US market.

Lupin said it has received US health regulator's approval to market generic version of Ortho-Novum tablets in the American market.

Drug major Lupin today said it has received US health regulator's approval for generic version of Teva Branded Pharm's Seasonique Tablets.